Trial ID: | L0353 |
Source ID: | NCT01087749
|
Associated Drug: |
Propranolol
|
Title: |
Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers
|
Acronym: |
CKD
|
Status: |
COMPLETED
|
Study Results: |
NO
|
Results: |
|
Conditions: |
Kidney Disease
|
Interventions: |
DRUG: Propranolol|DRUG: Losartan|DRUG: Eprosartan
|
Outcome Measures: |
Primary: Pharmacokinetic parameters, Three 12-hour days visits (on different weeks) will be investigated to obtain blood samples for 12 hours for three different medications. Blood samples will be obtained to determine the medication concentration in the plasma. There is no therapeutic effect on this study, since patients will receive a low single dose of the medication, and we'll assess the different pharmacokinetic parameters based on the concentrations of the medicine in plasma., 3 weeks |
|
Sponsor/Collaborators: |
Sponsor: University of California, San Francisco
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
PHASE1
|
Enrollment: |
24
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
|
Start Date: |
2010-03
|
Completion Date: |
2012-12
|
Results First Posted: |
|
Last Update Posted: |
2013-05-30
|
Locations: |
Clinical Reserach Center, UCSF, San Francisco,, California, 94143, United States
|
URL: |
https://clinicaltrials.gov/show/NCT01087749
|